Filtros de búsqueda

Lista de obras de Alexandria P Cogdill

Affinity-Tuned ErbB2 or EGFR Chimeric Antigen Receptor T Cells Exhibit an Increased Therapeutic Index against Tumors in Mice

artículo científico publicado en 2015

Androgen receptor blockade promotes response to BRAF/MEK-targeted therapy

artículo científico publicado en 2022

B cells and tertiary lymphoid structures promote immunotherapy response

artículo científico publicado en 2020

BRAF inhibition is associated with enhanced melanoma antigen expression and a more favorable tumor microenvironment in patients with metastatic melanoma.

artículo científico publicado en 2013

COT drives resistance to RAF inhibition through MAP kinase pathway reactivation

artículo científico publicado en 2010

Checkpoint Blockade Reverses Anergy in IL-13Rα2 Humanized scFv-Based CAR T Cells to Treat Murine and Canine Gliomas

artículo científico publicado en 2018

Combination anti-CTLA-4 plus anti-PD-1 checkpoint blockade utilizes cellular mechanisms partially distinct from monotherapies

scientific article published on 21 October 2019

Disruption of TET2 promotes the therapeutic efficacy of CD19-targeted T cells

artículo científico publicado en 2018

Distinct Cellular Mechanisms Underlie Anti-CTLA-4 and Anti-PD-1 Checkpoint Blockade

artículo científico publicado en 2017

EGFR-Mediated Reactivation of MAPK Signaling Contributes to Insensitivity of BRAF-Mutant Colorectal Cancers to RAF Inhibition with Vemurafenib

artículo científico publicado el 16 de enero de 2012

Elucidating the gut microbiota composition and the bioactivity of immunostimulatory commensals for the optimization of immune checkpoint inhibitors

scientific article published on 20 July 2020

Engineered CAR T Cells Targeting the Cancer-Associated Tn-Glycoform of the Membrane Mucin MUC1 Control Adenocarcinoma

scientific article published on June 2016

Gene Targeting Meets Cell-Based Therapy: Raising the Tail, or Merely a Whimper?

artículo científico publicado en 2016

Gene therapy with human and mouse T-cell receptors mediates cancer regression and targets normal tissues expressing cognate antigen

artículo científico publicado en 2009

Genomic and immune heterogeneity are associated with differential responses to therapy in melanoma.

artículo científico publicado en 2017

Gut microbiome modulates response to anti-PD-1 immunotherapy in melanoma patients.

artículo científico publicado en 2017

Hallmarks of response to immune checkpoint blockade

artículo científico publicado en 2017

Ibrutinib enhances chimeric antigen receptor T-cell engraftment and efficacy in leukemia

artículo científico publicado en 2016

Immunodynamics of explanted human tumors for immuno-oncology

artículo científico publicado en 2020

Potential role of 5-aza-2'-deoxycytidine induced MAGE-A4 expression in immunotherapy for anaplastic thyroid cancer

artículo científico publicado en 2013

Rational development and characterization of humanized anti-EGFR variant III chimeric antigen receptor T cells for glioblastoma

artículo científico publicado en 2015

Targeting the MAGE A3 antigen in pancreatic cancer

artículo científico publicado el 6 de julio de 2012

The Impact of Intratumoral and Gastrointestinal Microbiota on Systemic Cancer Therapy

artículo científico publicado en 2018

The Rationale and Emerging Use of Neoadjuvant Immune Checkpoint Blockade for Solid Malignancies.

artículo científico publicado en 2018

The human tumor microbiome is composed of tumor type-specific intracellular bacteria

artículo científico publicado en 2020